MAP1LC3B and HIV infectious disease: TFEB silencing (Fig 5A) significantly reduced both the lipidation of LC3B and the degradation of SQSTM1 in macrophages post-HIV infection (Fig 5B) in the absence of significant cytotoxic effects (P > 0.05; S2I Fig).